|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.71/-0.96
|
企业价值
88.27M
|
资产负债 |
每股账面净值
-0.46
|
现金流量 |
现金流量率
--
|
损益表 |
收益
1.75M
|
每股收益
0.03
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/04 20:00 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform. It has a scalable business model integrating clinical resources in the United States and China. |